Purchase Order HT942524P0115

Award Date 8/1/24
Potential Completion Date 8/27/29
Potential Value $438K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Burlingame, CA 94010, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke (NINDS) awarded a $5,095,804 firm fixed price purchase order contract to Collaborative Drug Discovery, Inc. (doing business as Molecular Databank), a small business provider of software solutions and informatics systems for drug discovery and development. The contract is for the development of a centralized information technology system to collect, maintain, and analyze chemical structure and...
This federal contract award, valued at $233,462.41, was issued by the Defense Health Agency (DHA) to Four LLC, a Virginia-based information technology solutions provider. The contract provides a perpetual software license for the Discovery Studio product to support the agency's research efforts, along with four optional periods of technical support. The contract was awarded under the Information Technology Enterprise Solutions-Software 2 (ITES2) Indefinite Delivery/Indefinite Quantity (IDIQ)...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $11,405.34 for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through December 5, 2023. The contract is a Firm Fixed Price award with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $199,439.33 and an ultimate completion date of June 26, 2025. The contract is not set aside and was awarded under Amerisourcebergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $15,346.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CABOMETYX 40 MG TABLET 30S, a pharmaceutical product. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $16,445.10 and is a firm fixed-price arrangement. The award is not associated with a set-aside program. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999.00....
This federal contract award, with an ID of SPE2DB22D3501|SPE2DB24FVX17, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $24,988.50 firm-fixed-price contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,039.32 Firm Fixed Price Delivery Order is for the supply of CABOMETYX 40 MG TABLET 30S, a pharmaceutical product, with a period of performance running through December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $19,836.92 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with an ultimate completion date of October 17, 2023. The award is not associated with a set-aside program and appears to be part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Venclexta 100 mg tablets. The contract is a delivery order with a firm fixed price of $8,880.15 and a completion date of May 16, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...

The U.S. Defense Health Agency awarded a $438,070.00 firm fixed price purchase order to Collaborative Drug Discovery, Inc., doing business as Molecular Databank, for a Collaborative Drug Discovery Vault subscription. The Vault is a hosted scientific data management system providing cloud-based biological and chemical databases, machine learning technologies, and data management capabilities to support drug discovery and development. This contract award has no set-aside designation and will be performed in Burlingame, California. Collaborative Drug Discovery is an established provider of informatics solutions for pharmaceutical research, having also received several federal grants from agencies like the National Center for Advancing Translational Sciences to develop advanced computational tools and frameworks for drug discovery.

Generated 10/30/24, 9:45 AM